7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,646.89

+635.66

+0.83%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Delayed Quote USD

Edesa Biotech, Inc. (EDSA)

2.5700 -0.1100 (-4.10%)

At close: October 30 at 4:00:01 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study

GlobeNewswire 16d ago

EDSA
-4.10%
EDSA: Recruitment in Phase 2 Vitiligo Study Set to Get Underway

Zacks Small Cap Research 2mo ago

EDSA
-4.10%
Edesa Biotech Stock Sinks After Fresh Capital Raise

Benzinga 2mo ago

EDSA
-4.10%
Edesa Biotech Announces Proposed Public Offering

GlobeNewswire 2mo ago

EDSA
-4.10%
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results

GlobeNewswire 2mo ago

EDSA
-4.10%
EDSA: Positive Exploratory Data in Patients with AKI

Zacks Small Cap Research 3mo ago

EDSA
-4.10%
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors

GlobeNewswire 4mo ago

EDSA
-4.10%
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

GlobeNewswire 4mo ago

EDSA
-4.10%
EDSA: Preparing for Mid-2026 Start to Phase 2 Vitiligo Trial

Zacks Small Cap Research 5mo ago

EDSA
-4.10%
EDSA: Preparing for Mid-2026 Start to Phase 2 Vitiligo Trial

Zacks Small Cap Research 5mo ago

EDSA
-4.10%
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

GlobeNewswire 5mo ago

EDSA
-4.10%
Edesa Biotech Reaches US$68m Market Cap Benefiting Insider Stock Buying

Simply Wall St. 6mo ago

EDSA
-4.10%

Performance Overview

Return	EDSA	S&P 500 (^GSPC)
YTD	+80.99%	+10.73%
1-Year	+37.43%	+11.11%
3-Year	-18.41%	+81.91%

Mobilize your Website

View Site in Mobile | Classic

Share by: